Advances in Urology / 2012 / Article / Tab 3

Research Article

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis

Table 3

Univariable cox regression models for comparing groups 1 and 2; endpoint: biochemical recurrence and clinical progression. (For clinical progression follow-up data were available for 132 patients).

Biochemical progressionClinical progression
HR (95% CI) valueHR (95% CI) value

Whole sample0.15 (0.08–0.29)<0.0010.21 (0.08–0.6)0.003
Low Gleason <70.16 (0.08–0.31)<0.0010.25 (0.08–0.8)0.02
High Gleason ≥70.11 (0.01–0.86)0.040.18 (0.02–1.6)n.s.
R00.13 (0.03–0.48)0.0021.15 (0.1–13.4)n.s.
R10.16 (0.75–0.32)<0.0010.15 (0.04–0.53)<0.01
pT3an.s.n.s.n.s.n.s.
pT3b0.15 (0.08–0.29)<0.0010.26 (0.09–0.75)0.013
pT40.22 (0.02–2.1)n.s.n.s.n.s.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.